Campbell & Co Investment Adviser’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,623
Closed -$337K 1081
2022
Q4
$337K Sell
2,623
-8,094
-76% -$1.04M 0.08% 504
2022
Q3
$1.47M Buy
10,717
+9,295
+654% +$1.51M 0.33% 49
2022
Q2
$252K Buy
+1,422
New +$205K 0.07% 525
2019
Q2
Sell
-3,007
Closed -$220K 744
2019
Q1
$220K Buy
+3,007
New +$214K 0.11% 405
2017
Q4
Sell
-5,356
Closed -$291K 540
2017
Q3
$291K Buy
+5,356
New +$274K 0.24% 168

Other funds holding SGEN

Campbell & Co Investment Adviser's SGEN Position: Q1 2023 in Review

Campbell & Co Investment Adviser sold out of Seagen Inc. Common Stock (SGEN) in Q1 2023, closing a stake of 2,623 shares — an estimated $337K sold.

Campbell & Co Investment Adviser first reported a position in SGEN in Q3 2017 and held it in 5 quarters. The position peaked at $1.47M in Q3 2022. 575 funds tracked by Wall St. Rank hold SGEN as of Q1 2023.

  • Campbell & Co Investment Adviser reported no remaining Seagen Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 2,623 Seagen Inc. Common Stock shares in Q1 2023, an estimated $337K.
  • Campbell & Co Investment Adviser first reported a position in Seagen Inc. Common Stock in Q3 2017 and held it in 5 quarters.
  • Campbell & Co Investment Adviser's Seagen Inc. Common Stock position peaked at $1.47M in Q3 2022.
  • 575 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q1 2023.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2023, filed 11 May 2023.